Heparina de bajo peso molecular (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Heparina de bajo peso molecular" in Spanish language version.

refsWebsite

Global rank Spanish rank

12nih.gov

4^th place

10doi.org

2^nd place

2semanticscholar.org

11^th place

79^th place

1tip.org.pl

low place

1annals.org

low place

6,230^th place

1web.archive.org

1^st place

1enotes.com

3,553^rd place

2,872^nd place

1archive.today

14^th place

19^th place

1harvard.edu

18^th place

34^th place

annals.org

Lim, Wendy; Dentali, Francesco; Eikelboom, John W. (2 de mayo de 2006). «Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency». Annals of Internal Medicine (en inglés) 144 (9): 673. doi:10.7326/0003-4819-144-9-200605020-00011.

archive.today

massgeneral.org > Heparin Antifactor Xa Assay Page Updated: September 18, 2009

doi.org

dx.doi.org

Weitz JI (Septiembre 1997). «Low-molecular-weight heparins». The New England Journal of Medicine (en inglés) 337 (10): 688-698. PMID 9278467. doi:10.1056/NEJM199709043371007.
Garcia DA, Baglin TP, Weitz JI, Samama MM (Febrero 2012). «Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines». Chest 141 (2 Suppl): e24S-e43S. PMC 3278070. PMID 22315264. doi:10.1378/chest.11-2291.
Hull RD (Marzo 2008). «Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings». Thrombosis and Haemostasis 99 (3): 502-510. PMID 18327398. S2CID 25247285. doi:10.1160/TH07-08-0500.
Snow V, Qaseem A, Barry P, Hornbake ER, Rodnick JE, Tobolic T, Ireland B, Segal JB, Bass EB, Weiss KB, Green L, Owens DK (Febrero de 2007). «Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians». Annals of Internal Medicine 146 (3): 204-210. PMID 17261857. doi:10.7326/0003-4819-146-3-200702060-00149.
Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA (February 2007). «Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients». Annals of Internal Medicine 146 (4): 278-288. PMID 17310052. S2CID 27605124. doi:10.7326/0003-4819-146-4-200702200-00007.
Montalescot G, Ellis SG, de Belder MA, Janssens L, Katz O, Pluta W, Ecollan P, Tendera M, van Boven AJ, Widimsky P, Andersen HR, Betriu A, Armstrong P, Brodie BR, Herrmann HC, Neumann FJ, Effron MB, Lu J, Barnathan ES, Topol EJ (Febrero de 2010). «Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)». JACC. Cardiovascular Interventions 3 (2): 203-212. PMID 20170878. doi:10.1016/j.jcin.2009.11.012.
Dumaine R, Borentain M, Bertel O, Bode C, Gallo R, White HD, Collet JP, Steinhubl SR, Montalescot G (Diciembre de 2007). «Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials». Archives of Internal Medicine 167 (22): 2423-2430. PMID 18071163. doi:10.1001/archinte.167.22.2423.
Lim, Wendy; Dentali, Francesco; Eikelboom, John W. (2 de mayo de 2006). «Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency». Annals of Internal Medicine (en inglés) 144 (9): 673. doi:10.7326/0003-4819-144-9-200605020-00011.
Hetzel GR, Sucker C (Octubre de 2005). «The heparins: all a nephrologist should know». Nephrology, Dialysis, Transplantation 20 (10): 2036-2042. PMID 16030035. doi:10.1093/ndt/gfi004.
Xu Y, Masuko S, Takieddin M, Xu H, Liu R, Jing J, Mousa SA, Linhardt RJ, Liu J (Octubre de 2011). «Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins». Science 334 (6055): 498-501. Bibcode:2011Sci...334..498X. PMC 3425363. PMID 22034431. doi:10.1126/science.1207478.

enotes.com

«enotes.com> Encyclopedia of Nursing & Allied Health - Coagulation Tests». Archivado desde el original el 18 de septiembre de 2010. Consultado el 24 de diciembre de 2022.

harvard.edu

adsabs.harvard.edu

Xu Y, Masuko S, Takieddin M, Xu H, Liu R, Jing J, Mousa SA, Linhardt RJ, Liu J (Octubre de 2011). «Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins». Science 334 (6055): 498-501. Bibcode:2011Sci...334..498X. PMC 3425363. PMID 22034431. doi:10.1126/science.1207478.

nih.gov

ncbi.nlm.nih.gov

Weitz JI (Septiembre 1997). «Low-molecular-weight heparins». The New England Journal of Medicine (en inglés) 337 (10): 688-698. PMID 9278467. doi:10.1056/NEJM199709043371007.
Linhardt RJ, Gunay NS (1999). «Production and chemical processing of low molecular weight heparins». Seminars in Thrombosis and Hemostasis (en inglés) 25 (Suppl 3): 5-16. PMID 10549711.
Garcia DA, Baglin TP, Weitz JI, Samama MM (Febrero 2012). «Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines». Chest 141 (2 Suppl): e24S-e43S. PMC 3278070. PMID 22315264. doi:10.1378/chest.11-2291.
Hull RD (Marzo 2008). «Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings». Thrombosis and Haemostasis 99 (3): 502-510. PMID 18327398. S2CID 25247285. doi:10.1160/TH07-08-0500.
Snow V, Qaseem A, Barry P, Hornbake ER, Rodnick JE, Tobolic T, Ireland B, Segal JB, Bass EB, Weiss KB, Green L, Owens DK (Febrero de 2007). «Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians». Annals of Internal Medicine 146 (3): 204-210. PMID 17261857. doi:10.7326/0003-4819-146-3-200702060-00149.
Douketis JD, Moinuddin I (Abril 2008). «Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence-based and practical approach». Polskie Archiwum Medycyny Wewnetrznej 118 (4): 209-215. PMID 18575420.
Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA (February 2007). «Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients». Annals of Internal Medicine 146 (4): 278-288. PMID 17310052. S2CID 27605124. doi:10.7326/0003-4819-146-4-200702200-00007.
Montalescot G, Ellis SG, de Belder MA, Janssens L, Katz O, Pluta W, Ecollan P, Tendera M, van Boven AJ, Widimsky P, Andersen HR, Betriu A, Armstrong P, Brodie BR, Herrmann HC, Neumann FJ, Effron MB, Lu J, Barnathan ES, Topol EJ (Febrero de 2010). «Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)». JACC. Cardiovascular Interventions 3 (2): 203-212. PMID 20170878. doi:10.1016/j.jcin.2009.11.012.
Dumaine R, Borentain M, Bertel O, Bode C, Gallo R, White HD, Collet JP, Steinhubl SR, Montalescot G (Diciembre de 2007). «Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials». Archives of Internal Medicine 167 (22): 2423-2430. PMID 18071163. doi:10.1001/archinte.167.22.2423.
Cardiovascular Disease Educational Research Trust; Cyprus Cardiovascular Disease Educational Research Trust; International Surgical Thrombosis Forum; International Union of Angiology; Union Internationale de Phlébologie (Junio 2006). «Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence)». International Angiology 25 (2): 101-161. PMID 16763532.
Hetzel GR, Sucker C (Octubre de 2005). «The heparins: all a nephrologist should know». Nephrology, Dialysis, Transplantation 20 (10): 2036-2042. PMID 16030035. doi:10.1093/ndt/gfi004.
Xu Y, Masuko S, Takieddin M, Xu H, Liu R, Jing J, Mousa SA, Linhardt RJ, Liu J (Octubre de 2011). «Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins». Science 334 (6055): 498-501. Bibcode:2011Sci...334..498X. PMC 3425363. PMID 22034431. doi:10.1126/science.1207478.

semanticscholar.org

api.semanticscholar.org

Hull RD (Marzo 2008). «Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings». Thrombosis and Haemostasis 99 (3): 502-510. PMID 18327398. S2CID 25247285. doi:10.1160/TH07-08-0500.
Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA (February 2007). «Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients». Annals of Internal Medicine 146 (4): 278-288. PMID 17310052. S2CID 27605124. doi:10.7326/0003-4819-146-4-200702200-00007.

tip.org.pl

Douketis JD, Moinuddin I (Abril 2008). «Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence-based and practical approach». Polskie Archiwum Medycyny Wewnetrznej 118 (4): 209-215. PMID 18575420.

web.archive.org

«enotes.com> Encyclopedia of Nursing & Allied Health - Coagulation Tests». Archivado desde el original el 18 de septiembre de 2010. Consultado el 24 de diciembre de 2022.